Ekso Bionics Holdings, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Segment Disclosures (Tables)

Segment Disclosures (Tables)

3 Months Ended

Mar. 31, 2015

Schedule of Segment Reporting Information

	Engineering		Medical
	Services		Devices		Total
Three months ended March 31, 2015
Revenue	$	704	$	985	$	1,689
Cost of revenue		488		798		1,286
Gross profit	$	216	$	187	$	403

Three months ended March 31, 2014
Revenue	$	535	$	527	$	1,062
Cost of revenue		252		330		582
Gross profit	$	283	$	197	$	480

Schedule of Geographic Information

	Three Months Ended March 31,
	2015		2014
North America	$	1,271	$	890
All Other		418		172
	$	1,689	$	1,062

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References + Details